152例肺癌脑转移立体定向放疗预后分析

doi:10.3760/cma.j.issn.1004-4221.2012.02.004

摘要
图/表
参考文献()
相关文章 (15)
点击分布统计
下载分布统计

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

摘要目的分析肺癌脑转移的立体定向放疗(SRT)疗效和预后因素。方法回顾分析行SRT的 152例肺癌脑转移病例。单纯SRT组 59例,SRT加全脑放疗(WBRT)组 40例,WBRT失败后SRT挽救组 53例。Logrank法单因素分析,Cox模型多因素分析。结果全组随访率为97.4%。单纯SRT组,SRT加WBRT组和SRT挽救组6个月、l年局部控制率分别为96.0%、93.4%,94.2%、90.8%和81.7%、77.5%(χ²=5.39,P=0.068),1、2、5年生存率分别为47.4%、23.7%、8.5%,55.0%、20.0%、0%和41.5%、7.5%、1.9%(χ²=4.08,P=0.130)。单因素分析显示诊断肺癌到脑转移时间、卡氏评分、肺癌切除、GPA分级、RPA分级、颅外病变是影响生存的因素(χ²=11.97、5.91、15.48、14.48、15.86、17.36,P=0.001、0.015、0.000、0.000、0.000、0.000)。多因素分析显示RPA分级、肺癌切除与总生存有关(χ²=21.02、8.18,P=0.000、0.004)。全组患者SRT前和后3个月卡氏评分≤70、80、90的比例分别为48.7%、33.6%、17.8%和27.0%、46.7%、26.3%(t=7.16,P=0.000)。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

关键词 ：肿瘤转移, 脑/放射疗法, 放射疗法, 立体定向, 放射疗法, 全脑, 预后

Abstract：Objective To assess the clinical efficacy and prognostic factors of Stereotactic Radiotherapy (SRT) for patients with brain metastases (BM) from lung cancer. Methods From March 1995 to July 2006, 152 consecutive patients with BM from lung cancer were treated by SRT, among them, 59 patients received SRT alone, 40 patients received SRT plus whole brain radiotherapy (SRT+WBRT), and 53 patients were salvaged by SRT after WBRT (salvaged group). Log-rank method was used for univariate analyses. Cox regression model was used for multivariate analyses. Results The follow-up rate was 97.4%. The half year and 1 year local control rate for SRT alone group, SRT+WBRT group and salvage group were 96.0% and 93.4%,94.2% and 90.8%,81.7% and 77.5%(χ²=5.39,P=0.068) respectively. The 1-,2-,5 year survival rate for SRT alone group, SRT+WBRT group and salvage group were 47.4%, 23.7%, 8.5%;55.0%, 20.0%,0%;41.5%,7.5%,1.9%, respectively. The median overall survival for each group was 11,12,11 months (χ²=4.08,P=0.130). The univariate analysis showed that the interval between diagnosis of lung cancer and BM, KPS, thoracic surgery, GPA grade, RPA class, system disease stable were significant prognostic factors (χ²=11.97, 5.91, 15.48, 14.48, 15.86, 17.36, P=0.001, 0.015, 0.000, 0.000, 0.000, 0.000).The multivariate analysis showed that the RPA class, thoracic surgery were the independent prognostic factors (χ²=21.02,8.18,P=0.000,0.004). KPS score less than 70, 80,90 for all patients before SRT and 3 months later after SRT were 48.7%, 33.6%,17.8% and 27.0%,46.7%,26.3% respectively (t=7.16,P=0.000). Conclusions A definitive benefit of SRT in the treatment BM from lung cancer is observed;there is no difference of survival among SRT alone, SRT+WBRT and salvage treatment. SRT can improve the patients′ KPS score. Thoracic surgery, RPA class were the independent prognostic factors for patients with BM from lung cancer.

Key words： Neoplasm metastases,brain/radiotherapy Radiotherapy, stereotactic Radiotherapy, whole brain Prognosis

收稿日期: 2011-07-11

基金资助:北京希望马拉松专项基金(LC2008A03)

引用本文:

. 152例肺癌脑转移立体定向放疗预后分析[J]. 中华放射肿瘤学杂志, 2012, 21(2): 108-111.

. Stereotactic Radiotherapy for Brain metastases from 152 lung cancer patients[J]. Chinese Journal of Radiation Oncology, 2012, 21(2): 108-111.

链接本文:

http://journal12.magtechjournal.com/Jweb_fszlx/CN/10.3760/cma.j.issn.1004-4221.2012.02.004 或 http://journal12.magtechjournal.com/Jweb_fszlx/CN/Y2012/V21/I2/108

[1] 王绿化,张红星,陈东福．肺癌//殷蔚伯,余子豪,徐国镇,等．肿瘤放射治疗学．4版．北京:中国协和医科大学出版社,2008:578.
[2] Tsao MN, Lloyd NS, Wong RK, et al. Radiotherapeutic management of brain metastases:a systematic review and meta-analysis. Cancer Treat Rev,2005,31:256-273.
[3] Kondziolka D, Patel A, Lunsford LD, et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys,1999,45:427-434.
[4] Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation:a randomised controlled trial. Lancet Oncol,2009,10:1037-1044.
[5] Kocher M, Soffietti R, Abacioglu U, et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases:results of the EORTC 22952-26001 study. J Clin Oncol,2011,29:134-141.
[6] Brown PD, Buckner JC, O′Fallon JR, et al. Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination. J Clin Oncol,2003,21:2519-2524.
[7] Manning MA, Cardinale RM, Benedict SH, et al. Hypofractionated stereotactic radiotherapy as an alternative to radiosurgery for the treatment of patients with brain metastases. Int J Radiat Oncol Biol Phys,2000,47:603-608.

[8] Noel G, Medioni J, Valery CA, et al. Three irradiation treatment options including radiosurgery for brain metastases from primary lung cancer. Lung Cancer,2003,41:333-343.
[9] Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases:a randomized controlled trial. JAMA,2006,295:2483-2491.
[10] Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys,1997,37:745-751.
[11] Videtic GM, Reddy CA, Chao ST, et al. Gender, race, and survival:a study in non-small-cell lung cancer brain metastases patients utilizing the radiation therapy oncology group recursive partitioning analysis classification. Int J Radiat Oncol Biol Phys,2009,75:1141-1147.
[12] Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases:final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys,2000,47:291-298.
[13] 姜雪松,肖建平,宋一昕,等．大于3 cm脑转移瘤分次立体定向放疗初探．中华放射肿瘤学杂志,2009,18:176-180.